Type I interferon in human autoimmunity

doi:10.3389/fimmu.2014.00306

. 2014 Jun 30:5:306.

doi: 10.3389/fimmu.2014.00306. eCollection 2014.

Type I interferon in human autoimmunity

Timothy B Niewold¹

Affiliations

PMID: 25071767
PMCID: PMC4074699
DOI: 10.3389/fimmu.2014.00306

Type I interferon in human autoimmunity

Timothy B Niewold. Front Immunol. 2014.

. 2014 Jun 30:5:306.

doi: 10.3389/fimmu.2014.00306. eCollection 2014.

Author

Timothy B Niewold¹

Affiliation

¹ Division of Rheumatology and Department of Immunology, Mayo Clinic , Rochester, MN , USA.

PMID: 25071767
PMCID: PMC4074699
DOI: 10.3389/fimmu.2014.00306

No abstract available

Keywords: Sjogren’s syndrome; autoimmune thyroid disease; interferons; multiple sclerosis; scleroderma; systemic; systemic lupus erythematosus; type I diabetes.

PubMed Disclaimer

Cited by

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
Sugrue JA, Bourke NM, O'Farrelly C. Sugrue JA, et al. Front Immunol. 2021 Nov 30;12:757249. doi: 10.3389/fimmu.2021.757249. eCollection 2021. Front Immunol. 2021. PMID: 34917078 Free PMC article. Review.
Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity.
Gao ZJ, Li WP, Mao XT, Huang T, Wang HL, Li YN, Liu BQ, Zhong JY, Renjie C, Jin J, Li YY. Gao ZJ, et al. J Exp Med. 2021 Mar 1;218(3):e20201798. doi: 10.1084/jem.20201798. J Exp Med. 2021. PMID: 33616624 Free PMC article.
Autoimmunity gene IRGM suppresses cGAS-STING and RIG-I-MAVS signaling to control interferon response.
Jena KK, Mehto S, Nath P, Chauhan NR, Sahu R, Dhar K, Das SK, Kolapalli SP, Murmu KC, Jain A, Krishna S, Sahoo BS, Chattopadhyay S, Rusten TE, Prasad P, Chauhan S, Chauhan S. Jena KK, et al. EMBO Rep. 2020 Sep 3;21(9):e50051. doi: 10.15252/embr.202050051. Epub 2020 Jul 27. EMBO Rep. 2020. PMID: 32715615 Free PMC article.
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2.
Duncan CJA, Thompson BJ, Chen R, Rice GI, Gothe F, Young DF, Lovell SC, Shuttleworth VG, Brocklebank V, Corner B, Skelton AJ, Bondet V, Coxhead J, Duffy D, Fourrage C, Livingston JH, Pavaine J, Cheesman E, Bitetti S, Grainger A, Acres M, Innes BA, Mikulasova A, Sun R, Hussain R, Wright R, Wynn R, Zarhrate M, Zeef LAH, Wood K, Hughes SM, Harris CL, Engelhardt KR, Crow YJ, Randall RE, Kavanagh D, Hambleton S, Briggs TA. Duncan CJA, et al. Sci Immunol. 2019 Dec 13;4(42):eaav7501. doi: 10.1126/sciimmunol.aav7501. Sci Immunol. 2019. PMID: 31836668 Free PMC article.
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.
Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Bader-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonné Y, Kirchhoff F, Sanchez Garcia E, Charbit B, Leboulanger N, Jahrsdörfer B, Richard Y, Korganow AS, Münch J, Nisole S, Duffy D, Herbeuval JP. Smith N, et al. Sci Adv. 2019 Jul 10;5(7):eaav9019. doi: 10.1126/sciadv.aav9019. eCollection 2019 Jul. Sci Adv. 2019. PMID: 31309143 Free PMC article.

See all "Cited by" articles

References

1. Ghodke-Puranik Y, Niewold TB. Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumtol (2013) 8:657–6910.2217/ijr.13.58 - DOI - PMC - PubMed
1. Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjogren’s syndrome. Genes Immun (2009) 10:285–9610.1038/gene.2009.20 - DOI - PMC - PubMed
1. Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol (2012) 39:1238–4010.3899/jrheum.111467 - DOI - PMC - PubMed
1. Javed A, Reder AT. Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther (2006) 110:35–5610.1016/j.pharmthera.2005.08.011 - DOI - PubMed
1. Mavragani CP, Niewold TB, Chatzigeorgiou A, Danielides S, Thomas D, Kirou KA, et al. Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations. Front Immunol (2013) 4:238.10.3389/fimmu.2013.00238 - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Ghodke-Puranik Y, Niewold TB. Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumtol (2013) 8:657–6910.2217/ijr.13.58 - DOI - PMC - PubMed

[2] Ghodke-Puranik Y, Niewold TB. Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumtol (2013) 8:657–6910.2217/ijr.13.58 - DOI - PMC - PubMed

[3] Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjogren’s syndrome. Genes Immun (2009) 10:285–9610.1038/gene.2009.20 - DOI - PMC - PubMed

[4] Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjogren’s syndrome. Genes Immun (2009) 10:285–9610.1038/gene.2009.20 - DOI - PMC - PubMed

[5] Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol (2012) 39:1238–4010.3899/jrheum.111467 - DOI - PMC - PubMed

[6] Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol (2012) 39:1238–4010.3899/jrheum.111467 - DOI - PMC - PubMed

[7] Javed A, Reder AT. Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther (2006) 110:35–5610.1016/j.pharmthera.2005.08.011 - DOI - PubMed

[8] Javed A, Reder AT. Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther (2006) 110:35–5610.1016/j.pharmthera.2005.08.011 - DOI - PubMed

[9] Mavragani CP, Niewold TB, Chatzigeorgiou A, Danielides S, Thomas D, Kirou KA, et al. Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations. Front Immunol (2013) 4:238.10.3389/fimmu.2013.00238 - DOI - PMC - PubMed

[10] Mavragani CP, Niewold TB, Chatzigeorgiou A, Danielides S, Thomas D, Kirou KA, et al. Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations. Front Immunol (2013) 4:238.10.3389/fimmu.2013.00238 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Type I interferon in human autoimmunity

Affiliation

Type I interferon in human autoimmunity

Author

Affiliation

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Similar articles

Cited by

References

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources